Medication info
Izaltan Tablet 150 mg (Irbesartan)

Izaltan Tablet 150 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201101755 · Approved 2011.03.29 · Insurance code 643505920

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • nephropathy in type 2 diabetes patients
View approved original text

This medication is used in the treatment of hypertension, including essential hypertension. Additionally, it helps to prevent or suppress the progression of nephropathy in patients with type 2 diabetes who have hypertension. This drug effectively controls blood pressure, reducing the risk of complications and improving patient health.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus and neonate, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to this drug or its components, pregnant or nursing women, patients with severe liver impairment, patients with hereditary angioedema, patients with diabetes or severe renal impairment should not take this medication. Caution is warranted for elderly patients, patients with hyperkalemia, those with liver disease, heart disease patients, patients with decreased blood volume, and those with renal dysfunction, and careful monitoring and testing by a physician may be necessary as needed. Generally, the side effects of this drug are mild and temporary; however, symptoms such as dizziness, headaches, muscle pain, fatigue, dyspepsia, and rashes may occur. Severe side effects such as angioedema, hyperkalemia, hypotension, renal failure, liver dysfunction, hypoglycemia, and muscle disorders may occur, and medical personnel should be notified immediately if symptoms arise. This medication can affect liver and kidney function, so patients with liver or renal abnormalities should undergo regular blood tests and physical condition assessments. Due to its strong blood pressure-lowering effect, care should be taken when taking this with other antihypertensive medications to avoid hypotension or electrolyte imbalance. When taken with potassium supplements or potassium-sparing diuretics, the blood potassium level may rise to dangerous levels, so co-administration should be avoided or done under medical supervision. Interactions may also occur when taken with lithium or nonsteroidal anti-inflammatory drugs (NSAIDs), so consultation with medical personnel is needed. Women who are pregnant or planning to become pregnant should not take this drug, and nursing women are advised to discontinue breastfeeding if they take this medication. Safety in children has not been established, so it is preferable not to use it in pediatric patients. Elderly patients should begin with a low dose and use it cautiously due to the risk of excessive blood pressure reduction leading to stroke or similar risks. In case of overdose, symptoms such as hypotension, tachycardia, and bradycardia may appear and immediate treatment is required, as this medication cannot be removed by dialysis. This medication should be kept out of the reach of children and should be stored in its original container as transferring to another container may degrade its quality.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal injury
  • chest pain
Show 114 more
  • indigestion/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction disturbances
  • cardiac respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal bloating
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • chest pain
  • joint rigidity
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • hypersomnia
  • affective disorders
  • depression
  • sensory disturbances
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • nasal bleeding
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory disturbances
  • ear inflammation
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • hyperkalemia
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • hepatitis
  • liver function abnormalities
  • kidney failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • shock
  • syncope
  • loss of consciousness
  • kidney failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • sensory loss syndrome
  • hypertriglyceridemia
  • insomnia
  • dysgeusia
  • thirst
  • abdominal bloating
  • oral bleeding
  • increased sputum
  • decreased HDL
  • increased salivation
  • hyperreflexia
  • itching
  • agranulocytosis
  • leukopenia
  • erectile dysfunction
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering and should be kept in a cool, dry place below 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.